Product Name：Trimetazidine Dihydrochloride Modified-release Tablets

【Strength】35mg

【Pharmaceutical Form】Tablets

【Therapeutic Indications】The product is indicated in combination for the symptomatic treatment of adult patients with stable angina pectoris (angina) who are insufficiently controlled or who are intolerant to first-line anti-anginal treatment.